AU6516296A - Novel quinoxaline- and quinoxalinylalkane-phosphonic acids - Google Patents

Novel quinoxaline- and quinoxalinylalkane-phosphonic acids

Info

Publication number
AU6516296A
AU6516296A AU65162/96A AU6516296A AU6516296A AU 6516296 A AU6516296 A AU 6516296A AU 65162/96 A AU65162/96 A AU 65162/96A AU 6516296 A AU6516296 A AU 6516296A AU 6516296 A AU6516296 A AU 6516296A
Authority
AU
Australia
Prior art keywords
quinoxalinylalkane
phosphonic acids
novel quinoxaline
quinoxaline
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65162/96A
Other languages
English (en)
Inventor
Hans Allgeier
Robert Moretti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU6516296A publication Critical patent/AU6516296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU65162/96A 1995-07-10 1996-07-01 Novel quinoxaline- and quinoxalinylalkane-phosphonic acids Abandoned AU6516296A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH200995 1995-07-10
CH2009/95 1995-07-10
PCT/EP1996/002866 WO1997003079A1 (fr) 1995-07-10 1996-07-01 Nouveaux acides quinoxaline- et quinoxalinylalkane-phosphoniques

Publications (1)

Publication Number Publication Date
AU6516296A true AU6516296A (en) 1997-02-10

Family

ID=4223780

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65162/96A Abandoned AU6516296A (en) 1995-07-10 1996-07-01 Novel quinoxaline- and quinoxalinylalkane-phosphonic acids

Country Status (15)

Country Link
EP (1) EP0837864A1 (fr)
JP (1) JPH11508902A (fr)
KR (1) KR19990028839A (fr)
AU (1) AU6516296A (fr)
BR (1) BR9609644A (fr)
CA (1) CA2224718A1 (fr)
CZ (1) CZ5398A3 (fr)
HU (1) HUP9901345A3 (fr)
IL (1) IL122872A0 (fr)
NO (1) NO980095L (fr)
PL (1) PL324340A1 (fr)
SK (1) SK2798A3 (fr)
TR (1) TR199800022T1 (fr)
WO (1) WO1997003079A1 (fr)
ZA (1) ZA965800B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2264171T3 (es) * 1996-10-24 2006-12-16 Novartis Ag Acidos aminoalcanofosfonicos sustituidos.
US6841684B2 (en) 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
US6329369B1 (en) 1997-12-04 2001-12-11 Allergan Sales, Inc. Methods of treating pain and other conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118675A (en) * 1991-02-15 1992-06-02 American Home Products Corporation Quinoxaline phosphono-amino acids
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
SK2798A3 (en) 1998-07-08
NO980095D0 (no) 1998-01-09
IL122872A0 (en) 1998-08-16
JPH11508902A (ja) 1999-08-03
TR199800022T1 (xx) 1998-05-21
CA2224718A1 (fr) 1997-01-30
MX9800332A (es) 1998-07-31
KR19990028839A (ko) 1999-04-15
NO980095L (no) 1998-03-05
HUP9901345A2 (hu) 1999-08-30
PL324340A1 (en) 1998-05-25
CZ5398A3 (cs) 1998-06-17
WO1997003079A1 (fr) 1997-01-30
BR9609644A (pt) 1999-05-11
ZA965800B (en) 1997-01-10
HUP9901345A3 (en) 2000-01-28
EP0837864A1 (fr) 1998-04-29

Similar Documents

Publication Publication Date Title
AU6490396A (en) Substituted-pent-4-ynoic acids
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU6000496A (en) Phenylpyridazinones
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5147496A (en) Fucopeptides
AU1364995A (en) 5-vinyl- and 5-ethinyl-quinolone- carboxylic acids
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU4382896A (en) Acetylimidazobenzodiazepines
AU5500196A (en) Anti-transpirants
AU5108596A (en) Morphine-3-esters
AU6215196A (en) Piperidinylmethyloxazolidinones
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU6516296A (en) Novel quinoxaline- and quinoxalinylalkane-phosphonic acids
AU7290096A (en) Substituted benzylidenecyanoacetic esters
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU7565396A (en) Fluorobutenoyloxyacetamides
AU2609095A (en) Compartmentalizer
AU5878096A (en) Fasciotome
AU6124596A (en) Mercapto-bis-triazoles
AU4531096A (en) Foodpellet

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted